A new study shows death during and following heart bypass surgery can be reduced by using a common heart medication before the patient goes into the operating room.
The use of Beta-Blocker medicines proved both effective and safe. The family of medicines helps improve heart function, control blood pressure and reduces the chance for additional heart attacks.
Based on a study in this week's Journal of the American Medical Association, increasing pre-bypass surgery Beta-Blocker use from the present 60% to 85% could make a life saving difference among patients undergoing this surgery.
Bruce Ferguson, M.D. of Louisiana State University's Health Sciences Center conducted the study. "Patients who learn about Beta-Blockers and learn that there are data now that suggests that beta-blockers are helpful to them, should ask their cardiac surgeon and their cardiologists if they're on a Beta-Blocker and, if not, why not."